Clinical Trial Update: Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma [Phase 4]

View source ↗

Summary

Phase 4 trial assessing additive effects of QVAR to Seretide on surrogate markers of airway inflammation in refractory asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• QVAR (beclomethasone dipropionate inhalation aerosol)
• Seretide (fluticasone propionate/salmeterol)

Snippet

Sponsor: University of Dundee | Conditions: Asthma | Phase 4 | Status: COMPLETED